Are you thinking there
might be a BLUE/SGMO collaboration just because the May'15 ASGCT Molecular
Therapy paper has a footnote that lists Bluebird as the current address of one
(now actually 2) of the authors?
http://www.researchgate.net/publication/275896634_Clinical_Scale_Zinc_Finger_Nuclease-mediated_Gene_Editing_of_PD-1_in_Tumor_Infiltrating_Lymphocytes_for_the_Treatment_of_Metastatic_Melanoma
Clinical Scale Zinc
Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes
for the Treatment of Metastatic Melanoma
DeadeyeGame